#Diabetes #GestationalDiabetes #Pregnancy
#Metabolism
Gestational diabetes mellitus (GDM) is a form
of glucose intolerance that first appears during pregnancy, typically in the
second or third trimester. Its prevalence is
steadily increasing worldwide,
reaching up to
15% of pregnancies in certain regions, largely due to the
parallel rise in obesity and sedentary lifestyles. Although usually temporary,
GDM poses a significant public health challenge because of its
immediate and
long-term consequences for both maternal and fetal health.
For the mother, GDM significantly raises the
risk of
obstetric complications such as preeclampsia, cesarean delivery, and
postpartum infections. It is also a strong
predictive factor for the future
development of type 2 diabetes. For the child, in-utero exposure to chronic
hyperglycemia increases the risk of macrosomia, neonatal hypoglycemia, and
later, a higher risk of overweight, metabolic disorders, and type 2 diabetes
during adolescence or adulthood.
The treatment of GDM primarily relies on
tailored dietary management. However, current guidelines vary widely across
countries, and no clear consensus exists regarding the most effective dietary
approach to optimize both glycemic control and perinatal outcomes. Some
strategies emphasize a low glycemic index (GI), others limit carbohydrate
intake, or are based on proven dietary patterns such as the DASH diet.
In this context, the objective of this study
was to
compare the effectiveness of various dietary approaches in managing
gestational diabetes. By analyzing their impact on key indicators such as
fasting blood glucose, postprandial glucose, insulin resistance, and pregnancy
complications, the study aims to guide clinicians toward more targeted,
evidence-based nutritional recommendations.
Read next: Weight gain in pregnant women with gestational diabetes
Does blood sugar control come down to what’s on
the plate?
In this study, 28 randomized controlled trials involving a total of 2,666 women
with GDM were selected to compare seven dietary patterns: Low-GI (low glycemic
index), DASH, Low-carb, Low-GL (glycemic load), a combined Low-carb + DASH
diet, and two standard diets. The primary outcomes measured were fasting blood
glucose (FBG), two-hour postprandial blood glucose (2h-PBG), insulin resistance
(HOMA-IR), and obstetric outcomes (cesarean delivery, macrosomia, gestational
hypertension, prematurity).
The findings show that the
DASH diet is
the
most effective for glycemic regulation. It significantly reduces FBG, 2h-PBG,
and HOMA-IR, outperforming other diets including Low-GI. However, the Low-GI
diet still shows good results for postprandial glucose and insulin resistance.
Regarding obstetric outcomes, the
DASH diet lowers the risk of cesarean
delivery, while the
Low-GI diet is more effective in preventing macrosomia and
prematurity. The Low-GI diet also shows a notable effect on reducing gestational
hypertension. In contrast,
Low-carb diets appear overall less effective,
particularly in controlling postprandial glucose and preventing complications.
Read next: Pregnancy and weight: a winning balance?
The DASH diet shines, but beware of biases
Gestational diabetes is a transient metabolic disorder with significant
impacts, requiring rigorous nutritional management. Its treatment largely
depends on nutritional interventions, which must meet three essential criteria:
ensure effective glycemic control, prevent obstetric complications, and remain
practical and culturally acceptable for patients. This delicate balance makes
the choice of diet particularly strategic.
This study sought to compare multiple diets to
identify the most appropriate strategies. It shows that the
DASH and Low-GI
diets stand out in terms of both
glycemic control and
reduction of
maternal-fetal complications. The DASH diet appears more effective for
metabolic markers, while the Low-GI diet excels at preventing macrosomia and
hypertension.
However, several limitations must be taken into
account, underscoring the need for further research. Future perspectives
include conducting larger, better-standardized prospective trials adapted to
diverse clinical settings. Harmonizing the tested dietary regimens and
improving the assessment of patient adherence are necessary to refine
nutritional recommendations for managing gestational diabetes.
Read next: Pre-Baby Boost: The Supplements That Make a Difference
